Her2 gene expression and not Her2 amplification is predictive and prognostic in patients (pts) with metastatic colorectal cancer (mCRC) enrolled in CALGB/SWOG 80405 (Alliance)
   Google Scholar   
Citation:
J. Clin. Oncol vol 38 (15 suppl) abstr 4086
Meeting Instance:
ASCO 2020
Year:
2020
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
SDC:
No
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
BMS. Genentech, Pfizer, Sanofi  
Grants:
U10CA180821, U10CA180882; U10CA180888, UG1CA180830 (SWOG)  
Corr. Author:
 
Authors:
                             
Networks:
ADM401, ADM402, ADM403, ALLIANCE, CA136, CA249, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-OH007, OR013, WV025   
Study
CALGB-80405
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: